Biotech player Brain gets boost from investor

By Simon Pitman

- Last updated on GMT

Biotech player Brain gets boost from investor

Related tags Carbon dioxide

Germany-based biotech ingredient player Brain has received a boost to its longer-term expansion goals thanks to support from a new investor.

DAH Beteiligungs has subscribed to a total of 1,641,434 new-registered no-par-value shares, which corresponds to a 10% share of the company’s total capital.

As part of Brain’s future expansion plans, company executives say that the boost to its funds will help to fund a new acquisition that will give the company scope for further expansion in the future.

One of Brain’s primary focuses is the cosmetics and personal care arena, for which it develops natural-based bioactive ingredients that mainly target the skin care category.

Investing in sustainability

The company is also aiming to make its business model more sustainable by investing in production processes that are both more efficient and better for the environment.

“The aim is to reduce the dependency on valuable, limited raw materials in favour of more sustainability, nature and climate protection,”​ said Dr Juergen Eck, CEO of Brain.

“Examples of this are our DOLCE program for the reduction of sugar consumption, our BioXtractor system for the extraction of precious metals from waste streams, or the use of the greenhouse gas carbon dioxide as a raw material.“

More biotech products planned

The investment by Beteiligungs’ capital comes 18 months after the company’s initial IPO and will increase the company’s share capital from Euros 16.4 million to Euros 18 million.

“Brain has been pursuing a successful growth strategy for several years,”​ said Frank Goebel, CFO of Brain.

“The goal is, in addition to intensifying research collaborations with industrial partners, to develop and market our own biotechnological product candidates. In line with this strategy, the proceeds from the capital increase shall primarily be used to finance small and medium-sized acquisitions. Consequently, also our shareholders will benefit from our sustainable corporate strategy.”

Related news

Related products

show more

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Get your skin ready for summer

Get your skin ready for summer

Content provided by Robertet Health & Beauty | 27-Jun-2023 | Product Brochure

Sunbathing at the beach is the first UV-related skin damage that comes to mind. Whereas, enjoying a coffee on a terrace under the sun can be as harmful.

Related suppliers

Follow us

Products

View more

Podcast

Beauty 4.0 Podcast